Digital Health
The cuffless device uses a sensor array over the radial artery to produce a pressure waveform that's used to determine systolic and diastolic blood pressure.
It has been approved as a prescription-only software-as-a-medical device in the US.
The company has received backing from the state government of Western Australia.
The funds will support its expansion across India.
Happify Health chief strategy officer Chris Wasden discusses the company's partnership strategy, the business environment for digital therapeutics and how to encourage physician uptake.
However, the review noted some concerns still need to be addressed, like data privacy and security.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
Swing Therapeutics CEO Mike Rosenbluth discusses the company's fibromyalgia management tool and what's necessary to make digital therapeutics mainstream.
In February, Ro announced a $150 million fundraise that bumped its valuation to $7 billion.
They plan to release their digital solutions for insurance companies next year.